Search Results

You searched for : octapharma

	Positive Results From ProDERM Study of octagam® 10% in Patients With Dermatomyositis Meeting the Primary Endpoint Will Be Presented at ACR Convergence 2020 Octapharma announces that the final results from the phase III ProDERM study will be presented at the American College of Rheumatology (ACR) Convergence 2020 virtual ... Nov 07
	Octapharma announces FDA approval of updated NUWIQ® Prescribing Information to include immunogenicity data in previously untreated patients The development of inhibitors against exogenous FVIII can reduce the effectiveness of treatment and negatively impact a patient's long-term joint health and quality ... Oct 20
	Octapharma Group Delivered Strong Growth in Both Sales and Operating Income In 2019 Octapharma has seven R&D sites and six state-of-the-art manufacturing facilities in Austria, France, Germany, Mexico and Sweden, in addition to more ... Feb 17
	Octapharma Demonstrates Commitment to Improving Haemophilia and Allied Disorders Octapharma demonstrates commitment to improving haemophilia, a treatment at the 13th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)... Feb 08
	Update of Summary of Product Characteristics for Nuwiq® includes data on effective bleed protection with twice-weekly dosing with personalised prophylaxis Octapharma announced today that the European Medicines Agency has authorised an updated Summary of Product Characteristics (SmPC) for Nuwiq® that includes information on personalised prophylaxis ... Oct 01
5 Matching result(s) found!

-Advertisements-

Trending Now
	Fighting back against superbugs- A joint initiative by UK and India ResearchersMay 23, 2025
	Archish Fertility & IVF Launches #RainbowBaby Campaign to Raise Miscarriage Awareness and Inspire HopeMay 22, 2025
	Asian Hospital, Faridabad Becomes the First in the City to Launch Total Lab Automation with QuidelOrthoMay 22, 2025
	Sharda Care Healthcity appoints Dr. Chirag Tandon as Director of Internal MedicineMay 22, 2025
	Global Milestone in the Field of Robotic SurgeryMay 22, 2025
	Medanta conducts advanced first aid training for Gurugram Traffic PoliceMay 22, 2025
	When to Consult a Fertility Expert: Not Just After MarriageMay 22, 2025
	Ovulation Tracking: A Doctor’s Guide to Doing It RightMay 22, 2025
	Debunking IVF Myths: What Doctors SayMay 22, 2025
	Aster CMI Hospital Becomes India’s Largest Pediatric Liver Transplant Program Under Affordable Transplant InitiativeMay 21, 2025
	Point-of-care health technologies make a difference when deployed at point-of-needMay 21, 2025
	Remidio Launches its new device ‘Pristine’, Innovating AI-Powered Eye Diagnostics with Dual Brand Strategy May 21, 2025
	HCGMCC & SunAct Launch North Maharashtra’s 1st Centre Of Excellence In Cell & Gene TherapyMay 21, 2025
	Transforming dementia support through technology networkMay 21, 2025
	Endometriosis: The Pain You Shouldn’t IgnoreMay 21, 2025
	The Best Age to Freeze Your Eggs — Doctor’s AdviceMay 21, 2025
	Managing PCOS Without Birth Control: Fact or Fiction?May 21, 2025
	Hormonal Acne in Women: It’s Not Just CosmeticMay 21, 2025
	Is Spotting Between Periods Normal?May 21, 2025
	QNET India Launches #BuzzForEarth Campaign on World Bee DayMay 20, 2025

Search Results

Positive Results From ProDERM Study of octagam® 10% in Patients With Dermatomyositis Meeting the Primary Endpoint Will Be Presented at ACR Convergence 2020

Octapharma announces FDA approval of updated NUWIQ® Prescribing Information to include immunogenicity data in previously untreated patients

Octapharma Group Delivered Strong Growth in Both Sales and Operating Income In 2019

Octapharma Demonstrates Commitment to Improving Haemophilia and Allied Disorders

Update of Summary of Product Characteristics for Nuwiq® includes data on effective bleed protection with twice-weekly dosing with personalised prophylaxis

Trending Now